Septal Ablation with Radiofrequency Catheters Guided by Echocardiography for Treatment of Patients with Obstructive

Bruno P Valdigem1, Edileide B Correia1, Dalmo A R Moreira1

  • 1Instituto Dante Pazzanese de Cardiologia,São Paulo, SP - Brasil.

Insights

Transesophageal echocardiography-guided radiofrequency septal ablation effectively reduced left ventricular outflow tract obstruction in hypertrophic cardiomyopathy patients. This safe procedure offered sustained gradient reduction and symptom relief without major complications.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Imaging

Background:

  • Hypertrophic cardiomyopathy (HCM) can cause left ventricular outflow tract (LVOT) obstruction, leading to debilitating symptoms.
  • Pharmacological treatments may be insufficient for refractory symptoms, necessitating interventions like septal ablation.
  • Radiofrequency (RF) catheter septal ablation, guided by electroanatomic mapping, is effective but carries a risk of atrioventricular block.

Purpose of the Study:

  • To evaluate the long-term efficacy of transesophageal echocardiography (TEE)-guided septal ablation in relieving ventricular-arterial gradient in HCM patients.
  • To assess the impact of TEE-guided septal ablation on functional class and echocardiographic parameters.
  • To determine the safety profile of this interventional approach.

Main Methods:

  • Twelve patients with drug-refractory LVOT obstruction underwent TEE-guided endocardial septal ablation using RF energy.
  • Catheter placement was guided by TEE to target the area of maximal septal obstruction.
  • Temperature-controlled RF applications were performed sequentially, with gradient reassessment after each application.

Main Results:

  • Mean maximum gradients significantly decreased from 96.8±34.7 mmHg to 62.7±25.4 mmHg at three months (p=0.0036) and to 36.1±23.8 mmHg at one year (p=0.0001).
  • The procedure was well tolerated, with no instances of complete atrioventricular block or severe complications reported.
  • Sustained reduction in LVOT obstruction was observed throughout the follow-up period.

Conclusions:

  • TEE-guided septal ablation is an efficient and safe therapeutic option for managing LVOT obstruction in HCM.
  • The procedure demonstrates sustained effectiveness in gradient reduction and is a viable alternative to other invasive treatments.
  • This technique offers a promising approach for improving clinical outcomes in selected HCM patients.
Abstract